BioQuant
Discovering and developing drugs for oncology, inflammation, immunology, & metabolic diseases
(1987)
TSRL, Inc.
Developing drug delivery solutions
(1987)
Cartox
In vitro cardiotoxicity testing platform using mature human stem cell derived cardiomyocytes
Endectra
Endectra LLC is commercializing solid-state, real-time radiation detection technology to displace expensive crystal- and gas-based sensors in defense, industrial, and medical applications.
ExoDynamics
Smart, active spinal orthoses that provides support and mobility to users
MEKanistic Therapeutics
MEKanistic is innovating cancer therapies by advancing a novel class of selective kinase inhibitors rationally designed to target both EGFR and PI3K with a single molecule. This breakthrough design expands the therapeutic window while avoiding inherent toxicity challenges of multi-compound treatments. Preclinical studies of its lead drug MTX-531 show a high incidence of tumor regression with dramatically reduced toxicity.
